PHARMA MAR S.A.

It is an anticancer medicinal product used to treat advanced soft tissue sarcoma (when other drugs have not worked or cannot be used) and for the treatment of recurrent ovarian cancer, when combined with another drug called pegylated liposomal doxorubicin (PLD).

Dosage form: solution for infusion, powder and solvent for preparation

ATC: L01CX01